Oncobiologics (OTLK)
(Delayed Data from NSDQ)
$0.96 USD
-0.03 (-2.73%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $0.97 +0.01 (0.73%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Oncobiologics, Inc. has a market cap of $43.97M, which represents its share price of $0.99 multiplied by its outstanding shares number of 44.42M. As a small-cap company, OTLK's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
OTLK 0.96 -0.03(-2.73%)
Will OTLK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for OTLK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OTLK
OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug
Oncobiologics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates
OTLK: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for July 30th
OTLK Stock Falls on Failure to Meet Non-Inferiority Goal in AMD Study
Other News for OTLK
OTLK forms MACD Bullish Signal Line Cross on September 20
OTLK forms Narrow Range Bar on September 19
OTLK forms NR7 on September 17
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names